P&G to acquire supplements brand Thorne for $3.8 billion in health push
The $3.8 billion acquisition of supplements brand Thorne puts Procter & Gamble's health strategy in focus. Chief executive Shailesh Jejurikar told CNBC's "Squawk on the Street" that the deal is meant to grow P&G's…
Key takeaways
- Procter & Gamble is acquiring supplements brand Thorne for $3.8 billion to expand its health business.
- P&G CEO Shailesh Jejurikar announced the deal on CNBC's "Squawk on the Street," stating its goal is to grow the company's health business.
- No additional financial terms beyond the $3.8 billion figure were disclosed in the interview.
- The announcement came via a CEO interview rather than a regulatory filing or press release.
- The definitive agreement and related filings detailing binding terms are the next confirmable milestones for P&G (PG) investors.
The $3.8 billion acquisition of supplements brand Thorne puts Procter & Gamble's health strategy in focus. Chief executive Shailesh Jejurikar told CNBC's "Squawk on the Street" that the deal is meant to grow P&G's health business. The definitive agreement is the next confirmable milestone for investors tracking P&G (PG).
The number on the tape
At $3.8 billion, the transaction sets a specific headline figure. Jejurikar offered the rationale directly on CNBC: the goal is health business growth. No additional financial terms were disclosed in the interview.
The size of the commitment tells its own story. A deal in the billions, announced by a sitting chief executive on a national financial network, is P&G making its health ambitions explicit.
What the deal signals
Jejurikar's framing on "Squawk on the Street" was clear: Thorne is a vehicle for expanding P&G's health presence. The supplements category is where the company is placing that bet. What the acquisition means in practice will become clearer once the formal agreement is on file.
A $3.8 billion acquisition is a durable commitment. It sets a floor on how seriously P&G's leadership is taking the health growth mandate.
What to watch
The announcement arrived via a CEO interview rather than a regulatory filing or press release. For investors in P&G (PG), the next hard data points are the definitive agreement and any filings that detail the deal's binding terms and conditions. Until those are public, $3.8 billion and Jejurikar's stated rationale are the only confirmed facts on the tape.